RACE Approved for 1 hour of CE credit
Target audience – Veterinarians & technicians
Did you know that 1 in 10 dogs have heart disease—and nearly 30% will progress to congestive heart failure (CHF)? The leading cause is Myxomatous Mitral Valve Disease (MMVD).Using real-world cases, this session brings clinical guidelines to life—clarifying when to intervene in asymptomatic dogs, how best to monitor progression, and what practical tools you can use when echocardiography isn’t readily available. The session will also highlight the growing role of AI-assisted diagnostics, with a focused look at the new Eko Vet+™ | CANINEBEAT AI® stethoscope .
You’ll learn how to:
- Screen and stage preclinical MMVD with confidence
- Recognize Stage B2 disease—even when echocardiography isn’t available
- Strengthen diagnostic accuracy with murmur grading and VHS/VLAS measurement
- Put the Eko Vet+™ | CANINEBEAT AI® stethoscope to work in your practice
- Build a follow‑up strategy that works in real-world clinical settings
Meet the Speaker:
Sonya Gordan, DVM, DACVIM
Responses